OP
Oasmia Pharmaceutical Stock: price and insider trades · Sweden
ISIN SE0013460540SE·
No insider purchase over the last 90 days. The latest, by Anette Sjödin, was filed 27 Nov 2019.
Oasmia Pharmaceutical: what insiders have been doing
Oasmia Pharmaceutical has a thin disclosure history in our data (latest filing: 27 November 2019). New filings will appear here as soon as they are published. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€4,591
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 27 November 2019
Declarations1 total
- 37,500 shares@ SEK 1.30100.0% of flowTeckningsrättISIN SE0013460540FI:csv-466d3e47e3b269077712Canonical exit: 23 Feb 2020 (T+90)
1 of 1 declaration
About Oasmia Pharmaceutical
Oasmia Pharmaceutical is a Swedish pharmaceutical company focused on developing treatments for cancer. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations